Vaccines Schedules
Browse our page to find out when to receive your follow-up vaccine doses, ensuring you maintain or extend your protection effectively.
To achieve full protection, it's recommended to complete all follow-up doses in the vaccination programme. Each subsequent dose builds on the initial vaccine, enhancing your immune response. Following the prescribed schedule ensures you receive the maximum benefits of the vaccine for effective protection against the disease.
| Age can be given | Method of Administration | Dosing Schedule | Interval between doses | Booster dose requirement |
|---|---|---|---|---|
| 12 months onwards | Intramuscular injection to the thigh or deltoid muscle depending on age | 2 doses | 4-8 weeks | None |
Post Exposure Prevention
To prevent infection from occurring in those who have never had chicken pox and have been exposed to infection (post exposure prevention): 2 doses of Chickenpox vaccine is required.
The first dose must be given within 3 days of the exposure to prevent the disease from developing. The first dose can be given 3-5 days from exposure to modify the severity of the disease.
After 5 days from exposure, there is no evidence that the vaccine will change the course of the infection and therefore, is not beneficial. The second dose should be given after 4 to 8 weeks.
| Age can be given | Method of Administration | Dosing Schedule | Interval between doses | Booster dose requirement |
|---|---|---|---|---|
| 12 months onwards | Intramuscular injection to the thigh or deltoid muscle depending on age | 2 doses | 4-8 weeks | None |
Post Exposure Prevention
To prevent infection from occurring in those who have never had chicken pox and have been exposed to infection (post exposure prevention): 2 doses of Chickenpox vaccine is required.
The first dose must be given within 3 days of the exposure to prevent the disease from developing. The first dose can be given 3-5 days from exposure to modify the severity of the disease.
After 5 days from exposure, there is no evidence that the vaccine will change the course of the infection and therefore, is not beneficial. The second dose should be given after 4 to 8 weeks.
| Age range | Vaccine Brand | Method of Administration | Number of doses | Interval Between doses | Booster Requirement |
|---|---|---|---|---|---|
| From 6 years of age onwards | Dukoral | Oral | 2 doses | Minimum interval 1 week Maximum interval 6 weeks | 2 years after 2nd dose if continuing risk |
| 2-6 years | Dukoral | Oral | 3 doses | Minimum interval 1 week Maximum interval 6 weeks | 6 months after 3rd dose if further risk of disease |
If an interval of more than 6 weeks has elapsed between doses, then the course needs to be restarted.
| Age range | Vaccine Brand | Method of Administration | Number of doses | Interval Between doses | Booster Requirement |
|---|---|---|---|---|---|
| From 6 years of age onwards | Dukoral | Oral | 2 doses | Minimum interval 1 week Maximum interval 6 weeks | 2 years after 2nd dose if continuing risk |
| 2-6 years | Dukoral | Oral | 3 doses | Minimum interval 1 week Maximum interval 6 weeks | 6 months after 3rd dose if further risk of disease |
If an interval of more than 6 weeks has elapsed between doses, then the course needs to be restarted.
| Age range | Method of Administration | Number of doses |
|---|---|---|
| From 4+ years | Injection | 2 doses, 2nd dose administered 3 months after 1st dose |
| Age range | Method of Administration | Number of doses |
|---|---|---|
| From 4+ years | Injection | 2 doses, 2nd dose administered 3 months after 1st dose |
Adult Schedule
The first dose should be given ideally 2 weeks before travel to the risk area.
| Vaccine Brand | Age | Method of Administration | Number of Doses | Interval Between Doses |
|---|---|---|---|---|
| Avaxim | From 16 years | Intramuscular injection to the deltoid muscle | 2 | 2nd dose should be given ideally 6-12 months after first. The 2nd dose can be given up to 3 years after the 1st dose. |
| Havrix Monodose | From 16 years | Intramuscular injection to the deltoid muscle | 2 | 2nd dose should be given ideally 6-12 months after first. The 2nd dose can be given up to 3 years after the 1st dose. |
| Vaqta Adult | From 16 years | Intramuscular injection to the deltoid muscle | 2 | 2nd dose should be given ideally 6-12 months after first. The 2nd dose can be given up to 3 years after the 1st dose. |
Children’s Schedule
| Vaccine Brand | Age Range | Method of Administration | Number of Doses | Interval Between Doses |
|---|---|---|---|---|
| Vaqta Paediatric | 1-17 years | Intramuscular Injection to the thigh or deltoid muscle | 2 | The 2nd dose should be given 6-12 months after the first dose. |
| Havrix Junior Monodose | 1-15 years | Intramuscular injection to the thigh or deltoid muscle | 2 | The 2nd dose should be given 6-12 months after the first dose. |
Booster Doses
Further single booster doses are required after 25 years for ongoing travel risk.
| Vaccine Brand | Age | Method of Administration | Number of doses |
|---|---|---|---|
| Hepatyrix | From 15 years | Intramuscular injection to the deltoid muscle | 1 |
Adult Schedule
The first dose should be given ideally 2 weeks before travel to the risk area.
| Vaccine Brand | Age | Method of Administration | Number of Doses | Interval Between Doses |
|---|---|---|---|---|
| Avaxim | From 16 years | Intramuscular injection to the deltoid muscle | 2 | 2nd dose should be given ideally 6-12 months after first. The 2nd dose can be given up to 3 years after the 1st dose. |
| Havrix Monodose | From 16 years | Intramuscular injection to the deltoid muscle | 2 | 2nd dose should be given ideally 6-12 months after first. The 2nd dose can be given up to 3 years after the 1st dose. |
| Vaqta Adult | From 16 years | Intramuscular injection to the deltoid muscle | 2 | 2nd dose should be given ideally 6-12 months after first. The 2nd dose can be given up to 3 years after the 1st dose. |
Children’s Schedule
| Vaccine Brand | Age Range | Method of Administration | Number of Doses | Interval Between Doses |
|---|---|---|---|---|
| Vaqta Paediatric | 1-17 years | Intramuscular Injection to the thigh or deltoid muscle | 2 | The 2nd dose should be given 6-12 months after the first dose. |
| Havrix Junior Monodose | 1-15 years | Intramuscular injection to the thigh or deltoid muscle | 2 | The 2nd dose should be given 6-12 months after the first dose. |
Booster Doses
Further single booster doses are required after 25 years for ongoing travel risk.
| Vaccine Brand | Age | Method of Administration | Number of doses |
|---|---|---|---|
| Hepatyrix | From 15 years | Intramuscular injection to the deltoid muscle | 1 |
Adult Schedule
| Vaccine Brand | Age | Method of Administration | Recommended Schedule | Number of doses |
|---|---|---|---|---|
| HBVaxPro | From 16 years | Intramuscular injection to the deltoid muscle | 1. Standard-0, 1, 6 months
2. Accelerated-0, 1, 2 and 12 months |
1. Standard schedule-3 doses 2. Accelerated schedule-4 doses |
| Engerix B (20mcg) | From 16 years | Intramuscular injection to the deltoid muscle | 1. Standard-0, 1, 6 months 2. Accelerated-0, 1, 2 and 12 months 3. Ultra-rapid-day 0, day 7 and day 21 and 12 months* |
1. Standard schedule-3 doses 2. Accelerated schedule-4 doses 3. Ultra-rapid schedule-4 doses |
*The ultra-rapid schedule can only be given to individuals over 16 years of age if there is insufficient time before travel for the accelerated course.
For occupational purposes, the Accelerated or standard schedule should be used.
Children’s Schedule
| Vaccine Brand | Age Range | Method of Administration | Recommended Vaccine Schedule | Number of Doses |
|---|---|---|---|---|
| HBVaxPro Paediatric (5mcg) | Birth to 15 years | Intramuscular Injection to the thigh or deltoid muscle | 1. Standard schedule-day 0, 1 month and 6 months 2. Accelerated schedule-day 0, 1 month, 2 months and 12 months |
1. Standard schedule-3 doses 2. Accelerated schedule-4 doses |
| Engerix B (10mcg) | Birth to 15 years | Intramuscular Injection to the thigh or deltoid muscle | 1. Standard schedule-day 0, 1 month and 6 months 2. Accelerated schedule-day 0, 1 month, 2 months and 12 months |
1. Standard schedule-3 doses 2. Accelerated schedule-4 doses |
Children under 16 years of age-the fastest schedule that can be used is the accelerated schedule.
There may be instances of under 16s requiring adult doses and that this will come down to the discretion of the clinician.
Booster Doses
In travellers, following completion of the full course, immunity is considered to be lifelong. A booster at 5 years is only required if there is high risk travel.
For occupational purposes, a booster is required at 5 years and further doses determined by blood testing.
Adult Schedule
| Vaccine Brand | Age | Method of Administration | Recommended Schedule | Number of doses |
|---|---|---|---|---|
| HBVaxPro | From 16 years | Intramuscular injection to the deltoid muscle | 1. Standard-0, 1, 6 months
2. Accelerated-0, 1, 2 and 12 months |
1. Standard schedule-3 doses 2. Accelerated schedule-4 doses |
| Engerix B (20mcg) | From 16 years | Intramuscular injection to the deltoid muscle | 1. Standard-0, 1, 6 months 2. Accelerated-0, 1, 2 and 12 months 3. Ultra-rapid-day 0, day 7 and day 21 and 12 months* |
1. Standard schedule-3 doses 2. Accelerated schedule-4 doses 3. Ultra-rapid schedule-4 doses |
*The ultra-rapid schedule can only be given to individuals over 16 years of age if there is insufficient time before travel for the accelerated course.
For occupational purposes, the Accelerated or standard schedule should be used.
Children’s Schedule
| Vaccine Brand | Age Range | Method of Administration | Recommended Vaccine Schedule | Number of Doses |
|---|---|---|---|---|
| HBVaxPro Paediatric (5mcg) | Birth to 15 years | Intramuscular Injection to the thigh or deltoid muscle | 1. Standard schedule-day 0, 1 month and 6 months 2. Accelerated schedule-day 0, 1 month, 2 months and 12 months |
1. Standard schedule-3 doses 2. Accelerated schedule-4 doses |
| Engerix B (10mcg) | Birth to 15 years | Intramuscular Injection to the thigh or deltoid muscle | 1. Standard schedule-day 0, 1 month and 6 months 2. Accelerated schedule-day 0, 1 month, 2 months and 12 months |
1. Standard schedule-3 doses 2. Accelerated schedule-4 doses |
Children under 16 years of age-the fastest schedule that can be used is the accelerated schedule.
There may be instances of under 16s requiring adult doses and that this will come down to the discretion of the clinician.
Booster Doses
In travellers, following completion of the full course, immunity is considered to be lifelong. A booster at 5 years is only required if there is high risk travel.
For occupational purposes, a booster is required at 5 years and further doses determined by blood testing.
| Age range | Vaccine Brand | Dose | Method of Administration | Number of doses primary course | Interval between doses primary course | First Booster dose requirements | Second Booster dose requirements |
|---|---|---|---|---|---|---|---|
| 2 months-3 years of age | Ixiaro | 0.25ml | Intramuscular injection to the thigh or deltoid muscle. | 2 doses | 2nd dose administered 28 days after 1st dose | If at ongoing risk for infection (such as travelling to live in endemic country)-First Booster at 12 months
All other Travellers-First Booster at 12-24 months |
Unknown |
| Children over 3 years up until 18 years | Ixiaro | 0.5ml | Intramuscular injection to the deltoid muscle | 2 doses | 2nd dose administered 28 days after 1st dose | If at ongoing risk for infection (such as travelling to live in endemic country)-First Booster at 12 months
All other Travellers-First Booster at 12-24 months |
Unknown |
| Adults 18 years-65 years | Ixiaro | 0.5ml | Intramuscular injection to the deltoid muscle | 2 doses | Standard Schedule=2 doses given at day 0 and day 28 Rapid Schedule-2 doses at day 0 and day 7 |
If at ongoing risk for infection (such as travelling to live in endemic country)-First Booster at 12 months
All other Travellers-First Booster at 12-24 months |
Second Booster at 10 years if at risk. |
| Age range | Vaccine Brand | Dose | Method of Administration | Number of doses primary course | Interval between doses primary course | First Booster dose requirements | Second Booster dose requirements |
|---|---|---|---|---|---|---|---|
| 2 months-3 years of age | Ixiaro | 0.25ml | Intramuscular injection to the thigh or deltoid muscle. | 2 doses | 2nd dose administered 28 days after 1st dose | If at ongoing risk for infection (such as travelling to live in endemic country)-First Booster at 12 months
All other Travellers-First Booster at 12-24 months |
Unknown |
| Children over 3 years up until 18 years | Ixiaro | 0.5ml | Intramuscular injection to the deltoid muscle | 2 doses | 2nd dose administered 28 days after 1st dose | If at ongoing risk for infection (such as travelling to live in endemic country)-First Booster at 12 months
All other Travellers-First Booster at 12-24 months |
Unknown |
| Adults 18 years-65 years | Ixiaro | 0.5ml | Intramuscular injection to the deltoid muscle | 2 doses | Standard Schedule=2 doses given at day 0 and day 28 Rapid Schedule-2 doses at day 0 and day 7 |
If at ongoing risk for infection (such as travelling to live in endemic country)-First Booster at 12 months
All other Travellers-First Booster at 12-24 months |
Second Booster at 10 years if at risk. |
The rapid schedule can be used if there is insufficient time to complete the standard schedule.
Adults between 18-65 years-rapid course of 2 doses Ixiaro given at day 0 and second dose 7 days later. This schedule provides the equivalent protection 7 days after the second dose as the standard schedule.
Additionally, the DOH guidance advises that clinical staff can adopt this ACCELERATED schedule “off license” in children aged 12-17 yrs also, if there is insufficient time before departing for their trip.
Exclusions
The vaccine cannot be given to:
- Infants under 2 months of age
- Individuals with a history of severe allergic reaction to previous dose of the vaccine or any of it’s components.
- Acute illness with high fever (greater than 38.5 degrees Celsius)
Pregnancy
There is insufficient data of the effects of the vaccine during pregnancy and therefore, it should not be administered to pregnant women.
Breast Feeding
Vaccination during breast feeding should be avoided due to lack of safety data.
Common Side Effects
Local injection site reactions including redness, swelling and pain.
Other side effects include fever, “flu-like” illness, muscle aches.
Interactions with Other Vaccines
The Japanese Encephalitis vaccine can be given at the same time as other vaccines including:
- Hepatitis A
- Hepatitis B
- Rabies
- Yellow fever
- Typhoid
- MMR
- Chicken Pox
- All childhood vaccines
The rapid schedule can be used if there is insufficient time to complete the standard schedule.
Adults between 18-65 years-rapid course of 2 doses Ixiaro given at day 0 and second dose 7 days later. This schedule provides the equivalent protection 7 days after the second dose as the standard schedule.
Additionally, the DOH guidance advises that clinical staff can adopt this ACCELERATED schedule “off license” in children aged 12-17 yrs also, if there is insufficient time before departing for their trip.
Exclusions
The vaccine cannot be given to:
- Infants under 2 months of age
- Individuals with a history of severe allergic reaction to previous dose of the vaccine or any of it’s components.
- Acute illness with high fever (greater than 38.5 degrees Celsius)
Pregnancy
There is insufficient data of the effects of the vaccine during pregnancy and therefore, it should not be administered to pregnant women.
Breast Feeding
Vaccination during breast feeding should be avoided due to lack of safety data.
Common Side Effects
Local injection site reactions including redness, swelling and pain.
Other side effects include fever, “flu-like” illness, muscle aches.
Interactions with Other Vaccines
The Japanese Encephalitis vaccine can be given at the same time as other vaccines including:
- Hepatitis A
- Hepatitis B
- Rabies
- Yellow fever
- Typhoid
- MMR
- Chicken Pox
- All childhood vaccines
Start taking Malarone 1-2 days before entering a malaria-endemic area. The tablet is taken daily, ideally at the same time each day, with food or a milky drink to enhance absorption.
Continue taking the medication every day while in the risk area. Importantly, to ensure that any remaining parasites in the blood are eradicated, continue taking Malarone for 7 days after leaving the endemic region.
This continuation after exposure is vital for the complete effectiveness of the prophylactic treatment. Missed doses significantly reduce protection effectiveness and should be avoided. If a dose is missed, take it as soon as remembered and resume the regular schedule.
Do not take a double dose to make up for the missed one. Consulting with a healthcare provider for personalised advice is always recommended, especially for extended stays in endemic regions.
To ensure maximum protection against malaria, adhering to the Malarone tablet schedule is crucial.
Start taking Malarone 1-2 days before entering a malaria-endemic area. The tablet is taken daily, ideally at the same time each day, with food or a milky drink to enhance absorption.
Continue taking the medication every day while in the risk area. Importantly, to ensure that any remaining parasites in the blood are eradicated, continue taking Malarone for 7 days after leaving the endemic region.
This continuation after exposure is vital for the complete effectiveness of the prophylactic treatment. Missed doses significantly reduce protection effectiveness and should be avoided. If a dose is missed, take it as soon as remembered and resume the regular schedule.
Do not take a double dose to make up for the missed one. Consulting with a healthcare provider for personalised advice is always recommended, especially for extended stays in endemic regions.
To ensure maximum protection against malaria, adhering to the Malarone tablet schedule is crucial.
| Age range | Method of Administration | Number of doses |
|---|---|---|
| From 12 months | Injection | 2 doses, second dose usually given before school entry but can be given any time from 18mths after the first dose |
| Age range | Method of Administration | Number of doses |
|---|---|---|
| From 12 months | Injection | 2 doses, second dose usually given before school entry but can be given any time from 18mths after the first dose |
For travel, Department of Health advice the following schedule:
| Age range | Vaccine Brand | Method of Administration | Schedule | Number of doses | Booster |
|---|---|---|---|---|---|
| From Birth to 1 year* | Menveo Only | Intramuscular injection to the thigh | First Dose Given Day 0
Second Dose Given One Month Later |
2 doses | Unknown |
| From 1 years of age onwards. | Menveo or Nimenrix | Intramuscular injection to the deltoid muscle | One Single Dose | 1 dose | Unknown |
*Although the vaccine licence for Menveo is from 2 years, there is sufficient study data showing that the vaccine is safe and effective in babies under 1 year of age. Hence, the Department of Health recommends Menveo can be used from birth.
Pilgrims to Saudi Arabia
Single dose of Meningitis ACWY vaccine given 10 days prior to entry.
Booster doses
General Travellers-the requirement for booster doses for travellers and other at risk groups is currently not know. Clinical study data shows protection lasts for around 5 years following one dose of the ACWY conjugated vaccine.
Pilgrims to Saudi Arabia-For Hajj/Umrah certificate/visa requirements, it is accepted that the vaccine lasts for 5 years (certificate should state conjugate vaccine used). Therefore, further booster would be needed if contemplating pilgrimage after this time period. However, if there is uncertainty as to whether a conjugated vaccine was administererd or ACWY Vax (GSK vaccine) was given, then the validity would be 3 years.
For travel, Department of Health advice the following schedule:
| Age range | Vaccine Brand | Method of Administration | Schedule | Number of doses | Booster |
|---|---|---|---|---|---|
| From Birth to 1 year* | Menveo Only | Intramuscular injection to the thigh | First Dose Given Day 0
Second Dose Given One Month Later |
2 doses | Unknown |
| From 1 years of age onwards. | Menveo or Nimenrix | Intramuscular injection to the deltoid muscle | One Single Dose | 1 dose | Unknown |
*Although the vaccine licence for Menveo is from 2 years, there is sufficient study data showing that the vaccine is safe and effective in babies under 1 year of age. Hence, the Department of Health recommends Menveo can be used from birth.
Pilgrims to Saudi Arabia
Single dose of Meningitis ACWY vaccine given 10 days prior to entry.
Booster doses
General Travellers-the requirement for booster doses for travellers and other at risk groups is currently not know. Clinical study data shows protection lasts for around 5 years following one dose of the ACWY conjugated vaccine.
Pilgrims to Saudi Arabia-For Hajj/Umrah certificate/visa requirements, it is accepted that the vaccine lasts for 5 years (certificate should state conjugate vaccine used). Therefore, further booster would be needed if contemplating pilgrimage after this time period. However, if there is uncertainty as to whether a conjugated vaccine was administererd or ACWY Vax (GSK vaccine) was given, then the validity would be 3 years.
| Age at first dose | Method of Administration | Number of doses | Interval Between Doses | Booster Requirement |
|---|---|---|---|---|
| 2-5 months | Intramuscular injection to the thigh | 3 doses | At least 1 month between each dose | Yes-One further dose given at 12-15 months of age |
| 6-11 months | Intramuscular injection to the thigh | 2 doses | At least 2 months between doses | Yes-One further dose given in 2nd year of life, at least 2 months after 2nd dose. |
| 12-23 months | Intramuscular injection to the thigh or deltoid muscle | 2 doses | At least 2 months between doses | Yes-One further dose given 1-2 years after the 2nd dose |
| 2-10 years of age | Intramuscular injection to the deltoid muscle | 2 doses | At least 1 month between each dose | Unknown |
| Over 11 years of age | Intramuscular injection to the deltoid muscle | 2 doses | At least 1 month between each dose | Unknown |
| Age at first dose | Method of Administration | Number of doses | Interval Between Doses | Booster Requirement |
|---|---|---|---|---|
| 2-5 months | Intramuscular injection to the thigh | 3 doses | At least 1 month between each dose | Yes-One further dose given at 12-15 months of age |
| 6-11 months | Intramuscular injection to the thigh | 2 doses | At least 2 months between doses | Yes-One further dose given in 2nd year of life, at least 2 months after 2nd dose. |
| 12-23 months | Intramuscular injection to the thigh or deltoid muscle | 2 doses | At least 2 months between doses | Yes-One further dose given 1-2 years after the 2nd dose |
| 2-10 years of age | Intramuscular injection to the deltoid muscle | 2 doses | At least 1 month between each dose | Unknown |
| Over 11 years of age | Intramuscular injection to the deltoid muscle | 2 doses | At least 1 month between each dose | Unknown |
| Age range | Method of Administration | Number of Doses | Interval Between Doses |
|---|---|---|---|
| From Birth onwards
Standard Schedule |
Injection | 3 doses | 2nd dose given minimum 7 days after first and third dose given minimum 14 days after 2nd dose. |
| From Birth onwards
Accelerated Schedule (where insufficient time for standard) |
Injection | 4 doses | 2nd dose given at least 3 days after first dose and 3rd dose given at least 4 days after 2nd. Followed by a 4th dose 12 months after dose 3. |
Post-exposure management
It is imperative to seek medical attention as soon as possible if a bite or scratch is sustained in any rabies endemic area even if pre-travel vaccination has been given. Saliva should be thoroughly washed with soap and water for 10 mins and the wound irrigated with iodine solution or alcohol. This is very effective in removing virus from the bite site, providing it is prompt and thorough. Suturing of the wound site should be avoided and tetanus vaccination should be considered. If you have returned back to the UK having suffered a bite/scratch in a rabies endemic area, your case will need to be discussed with Public Health England. This is the case even if you have started a post exposure exposure rabies course after a bite abroad and have been advised to complete in the UK, you will need to attend your local GP or AE, who can discuss your case directly with the Public Health England.
At CityDoc, we are not able to provide post exposure vaccination as this is done through Public Health England.
| Age range | Method of Administration | Number of Doses | Interval Between Doses |
|---|---|---|---|
| From Birth onwards
Standard Schedule |
Injection | 3 doses | 2nd dose given minimum 7 days after first and third dose given minimum 14 days after 2nd dose. |
| From Birth onwards
Accelerated Schedule (where insufficient time for standard) |
Injection | 4 doses | 2nd dose given at least 3 days after first dose and 3rd dose given at least 4 days after 2nd. Followed by a 4th dose 12 months after dose 3. |
Post-exposure management
It is imperative to seek medical attention as soon as possible if a bite or scratch is sustained in any rabies endemic area even if pre-travel vaccination has been given. Saliva should be thoroughly washed with soap and water for 10 mins and the wound irrigated with iodine solution or alcohol. This is very effective in removing virus from the bite site, providing it is prompt and thorough. Suturing of the wound site should be avoided and tetanus vaccination should be considered. If you have returned back to the UK having suffered a bite/scratch in a rabies endemic area, your case will need to be discussed with Public Health England. This is the case even if you have started a post exposure exposure rabies course after a bite abroad and have been advised to complete in the UK, you will need to attend your local GP or AE, who can discuss your case directly with the Public Health England.
At CityDoc, we are not able to provide post exposure vaccination as this is done through Public Health England.
| Age Range | Method of Administration | Number of Doses | Interval bewteen Doses | Booster Requirements |
|---|---|---|---|---|
| From 50 years of age | Intramuscular injection to the deltoid muscle of the upper arm | 2 | Ideally 2 months 2nd dose can be given up to 6 months after 1st dose. | Not Known |
Duration of Protection and Booster Doses
Study data shows persisting immunity up to 4 years after completion of 2nd dose. Duration of protection beyond this time frame is still being studied. The need for booster doses is unknown.
| Age Range | Method of Administration | Number of Doses | Interval bewteen Doses | Booster Requirements |
|---|---|---|---|---|
| From 50 years of age | Intramuscular injection to the deltoid muscle of the upper arm | 2 | Ideally 2 months 2nd dose can be given up to 6 months after 1st dose. | Not Known |
Duration of Protection and Booster Doses
Study data shows persisting immunity up to 4 years after completion of 2nd dose. Duration of protection beyond this time frame is still being studied. The need for booster doses is unknown.
| Age | Dose | Duration |
|---|---|---|
| Birth to 1 year (Please note, babies must be 9 months of age or have a negative neonatal SCID report for us to be able to administer this vaccine.) |
0.05mls single dose Left Deltoid Intradermal | Life |
| Age of 1 and over | 0.1mls single dose Left Deltoid Intradermal | Life |
The vaccine is administered into the skin of the upper arm, normally the left side.
There is no need for further doses of the BCG vaccine- it should be given only once in a lifetime.
| Age | Dose | Duration |
|---|---|---|
| Birth to 1 year (Please note, babies must be 9 months of age or have a negative neonatal SCID report for us to be able to administer this vaccine.) |
0.05mls single dose Left Deltoid Intradermal | Life |
| Age of 1 and over | 0.1mls single dose Left Deltoid Intradermal | Life |
The vaccine is administered into the skin of the upper arm, normally the left side.
There is no need for further doses of the BCG vaccine- it should be given only once in a lifetime.
| Age range | Method of Administration | Number of doses |
|---|---|---|
| From 2 years of age | Intramuscular injection to the deltoid muscle | 1 dose |
Booster Doses
There is no booster vaccination for typhoid, instead a new vaccination should be given every 3 years for ongoing risk.
| Age range | Method of Administration | Number of doses |
|---|---|---|
| From 2 years of age | Intramuscular injection to the deltoid muscle | 1 dose |
Booster Doses
There is no booster vaccination for typhoid, instead a new vaccination should be given every 3 years for ongoing risk.
The vaccine is administered as a booster dose only for individuals who have had the full course of 3 doses of the vaccine during childhood or had prior infection with whooping cough.
It is a single booster dose, which confers immunity for approximately 10 yrs.
Booster Doses
Further doses of the vaccine can be given at 10 years if required. It is given intramuscularly.
The vaccine is administered as a booster dose only for individuals who have had the full course of 3 doses of the vaccine during childhood or had prior infection with whooping cough.
It is a single booster dose, which confers immunity for approximately 10 yrs.
Booster Doses
Further doses of the vaccine can be given at 10 years if required. It is given intramuscularly.
| Age | Method of Administration | Number of Doses |
|---|---|---|
| From 9 months of age | Subcutaneous injection to the thigh or deltoid region of the upper arm | 1 |
Booster Doses
A single dose of the vaccine confers protection for life.
Booster doses are required in the following circumstances:
- The first dose of the vaccine was administered under 2 years of age
- The first dose of the vaccine was administered when pregnant
- The first dose of the vaccine was administered when immunosuppressed
| Age | Method of Administration | Number of Doses |
|---|---|---|
| From 9 months of age | Subcutaneous injection to the thigh or deltoid region of the upper arm | 1 |
Booster Doses
A single dose of the vaccine confers protection for life.
Booster doses are required in the following circumstances:
- The first dose of the vaccine was administered under 2 years of age
- The first dose of the vaccine was administered when pregnant
- The first dose of the vaccine was administered when immunosuppressed